Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

DNA - Dr. Emiel Rutgers, NL

RNA - Dr. Giuseppe Curigliano, IT

Emerging Technologies - Dr. Fabrice André, FR

Circulation Markers - Dr. Philippe Bedard, CA

Pathology - Professor Michael Gnant, AT

Methodology in Bio-Markers Research and Validation - Prof. Dr. Nadia Harbeck, DE

Opening Keynote Lecture: Interrogating the architecture of cancer genome - Dr. Martine Piccart, BE

DNA Repair as a Treatment Target - Professor Michael Gnant, AT

Best Abstracts - Clifford Hudis, US, Prof. Angelo Di Leo, IT, Dr. Fabrice André, FR, Prof. John Bartlett, UK

Keynote Lecture: A decade of translational research in breast cancer - Prof. Giuseppe Viale, IT, Dr. William Fraser Symmans, US

The next wave of molecular therapies - Prof.Dr. Jean-Charles Soria, FR, Professor Stephen Johnston, UK, Neil Rosen, US

Innovative Trials Design - Dr. Richard Gelber, US

Practice-Changing Discoveries in Translational Research - Prof. Aron Goldhirsch, IT

Special Educational Session: Tailoring of Endocrine Therapy - Dr. Kent Osborne, US, Dr. Eric Winer, US, Dr. Martine Piccart, BE

  • BIG 1-98 - Prof. Giuseppe Viale, IT
  • TEAM - Prof. John Bartlett, UK

Keynote Lecture: Cancer metabolism as a potential treatment target - Prof. Dr. Med Heikki Joensuu, FI

Breast Cancer Initiation and Metastatic Progression - Neil Rosen, US, Dr. Pamela Goodwin, CA

Is Anti-angiogenic Therapy Dead in Breast Cancer? - Jonas Bergh, SE

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings